Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X2TZ
|
|||
| Former ID |
DNCL003284
|
|||
| Drug Name |
Streptococcus pneumoniae vaccine
|
|||
| Synonyms |
Protein Streptococcus pneumoniae vaccine, sanofi pasteur; Streptococcus pneumoniaevaccine (protein); Pneumococcal vaccine (protein), sanofi pasteur; Streptococcus pneumoniae vaccine (protein), sanofi pasteur
Click to Show/Hide
|
|||
| Indication | Meningitis [ICD-11: 1D01] | Phase 1 | [1] | |
| Pneumonia [ICD-11: CA40] | Phase 1 | [1] | ||
| Streptococcus infection [ICD-11: 1B53; ICD-10: G00.1, G00.2] | Phase 1 | [2] | ||
| Company |
Sanofi pasteur
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Sanofi Pasteur. | |||
| REF 2 | Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine. Vaccine. 2012 Dec 14;30(52):7461-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.